Early Detection of Health Deterioration in Elderly Patients After Hospitalization for Heart Failure Decompensation

Heart Failure Clinical Trial

Official title:

Early Detection of Health Deterioration in Elderly Patients After Hospitalization for Heart Failure Decompensation: A Potential Role for Ambient Sensor Systems in the Patients Home

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06126848
• Other study ID #: eHealth-HF
• Status: Not yet recruiting
• Phase: N/A
• Start date: January 2024
• Est. completion date: March 2026

Study information

• Verified date: November 2023
• Source: Kantonsspital Olten
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Digital biomarkers extracted by ambient sensor signals are a promising tool for early detection of health deterioration in the setting of remote patient management of heart failure patients.The primary objective of the study is to evaluate new digital biomarkers as predictors of impending heart failure decompensation. Secondary objectives are (1) outcome assessment (re-hospitalizations, cardiovascular death, all-cause death), (2) quality of life and (3) System User Satisfaction (SUS)

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 24
• Est. completion date: March 2026
• Est. primary completion date: December 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 70 Years and older

Eligibility

Inclusion Criteria:

• admitted to hospital for worsening HF
• age = 70 years
• LVEF < 50% and need of diuretics
• NYHA II or III
• living alone
• willing to participate with informed consent.

Exclusion Criteria:

• Major depression (PHQ 9-score >9)
• being on hemodialysis
• had been admitted to hospital for any reason within 7 days before HF decompensation.
• patients with a left ventricular assist device
• coronary revascularization or cardiac resynchronization therapy implantation within 28 days before the index event of HF decompensation or have been scheduled for such interventions.

Related Conditions & MeSH terms

• Heart Failure

Intervention

Device:
• Ambient sensor system
Main study: A contactless non-intrusive ambient sensor system including infrared motion sensors combined with a contactless Emfit bed sensor will be installed in the home of single living study patients by using a commercially available System (Domo Health®, Lausanne) after informed consent has been obtained. Sensor data are prospectively followed over 3-6 months for predefined indicators of health deterioration. If indicators for health deterioration are present, patients will be called in to the hospital for cardiology consult by the study team including blood analysis for follow-up of BNP values and if necessary, therapy adaption.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Nisha Arenja

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sensitivity and specificity of ambient sensor derived digital biomarkers	Sensitivity and specificity of a combination of ambient sensor derived digital biomarker for the prediction of brain natriuretic peptide (BNP) increase of = 20% compared to baseline value.	6 months
Secondary	Outcome assessment	re-hospitalizations, cardiovascular death, all-cause death	6 months
Secondary	Quality of life (heart failure symptoms) - KCCQ	KCCQ scores are scaled from 0 to 100 and frequently summarized in 25-point ranges, where scores represent health status as follows: 0 to 24: very poor to poor; 25 to 49: poor to fair; 50 to 74: fair to good; and 75 to 100: good to excellent.	6 months
Secondary	System Usability Scale (SUS)	SUS score 0-100; 80.3 or higher is an A. People will recommend it to their friends 68 or there abouts gets you a C. You are doing OK but could improve 51 or under gets you a big fat F. Make usability your priority now and fix this fast.	6 months